02/14/2025 6:13 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:49 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:57 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:35 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:42 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:13 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:20 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:26 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:00 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:03 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 5:08 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NBIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
02/13/2025 3:33 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:33 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:33 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:34 PM | Neurocrine Biosciences (Subject) Onyia Jude (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:34 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:34 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:34 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:35 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:35 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:35 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:36 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:36 PM | Neurocrine Biosciences (Subject) Onyia Jude (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:36 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:37 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:37 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:37 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:37 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:38 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025 3:38 PM | Neurocrine Biosciences (Subject) SHERWIN STEPHEN A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2025 5:41 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:44 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:46 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:48 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:49 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:52 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:56 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 6:00 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2025 3:51 PM | Neurocrine Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/06/2025 3:04 PM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2025 5:50 AM | Neurocrine Biosciences (Subject) STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
02/04/2025 5:05 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:42 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:45 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:47 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:49 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:51 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:54 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:58 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:31 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/04/2025 4:35 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/03/2025 3:19 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:32 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:32 PM | Neurocrine Biosciences (Subject) ROBERTS EIRY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:33 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:34 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:29 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:27 PM | Neurocrine Biosciences (Subject) Onyia Jude (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:28 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:28 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:28 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2025 3:29 PM | BENEVICH ERIC (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025 6:03 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:27 PM | GORMAN KEVIN CHARLES (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025 3:19 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/31/2024 3:17 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024 7:06 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2024 3:37 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2024 3:47 PM | Neurocrine Biosciences (Issuer) ROBERTS EIRY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2024 3:29 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 5:52 PM | Neurocrine Biosciences (Issuer) Onyia Jude (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2024 12:41 PM | Neurocrine Biosciences (Subject) Onyia Jude (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 6:42 PM | Neurocrine Biosciences (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 6:52 PM | Gano Kyle (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 7:31 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 6:02 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 6:04 AM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/17/2024 8:54 AM | Neurocrine Biosciences (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
09/17/2024 3:21 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 3:23 PM | Boyer David W. (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2024 4:00 PM | Neurocrine Biosciences (Issuer) RASTETTER WILLIAM H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:06 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:12 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:21 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 4:16 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 4:18 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 4:40 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 9:51 AM | Neurocrine Biosciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024 6:03 AM | Neurocrine Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 6:04 AM | Neurocrine Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
The FED is losing the war on inflation (Ad) It's no longer just a “guesstimate” – Inflation is indeed getting worse.
And although we want to believe the Fed has a good grip on it, they don't.
Right now, the suits over there are caught between a rock and a hard place.
Either they watch as inflation grows, or they tear it down and send us into a full-blown recession.
The kicker here is that neither of these are good for you.
Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower.
The only real way out for the regular person is to increase your earning power.
By increasing your income to match prices as they flare up…
You’ll stay ahead of the impending doom we're running face-first into.
And if you're looking for a strategy to help increase your income in 2025…
I've got just the thing for you!
You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts
But I changed my trading rules and more than doubled my results on those 100 published trades.
I'm now calling them Warped Options… You can go here to give yourself a head start. |
07/18/2024 3:54 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 4:00 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 4:12 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 3:45 PM | ABERNETHY MATT (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 3:41 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:28 PM | Lippoldt Darin (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:29 PM | Cooke Julie (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:29 PM | LYONS GARY A (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 3:30 PM | Delaet Ingrid (Reporting) Neurocrine Biosciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |